CJC + IPA is a research-grade blend combining CJC-1295 Without DAC (5mg) and Ipamorelin (5mg) for synergistic growth hormone releasing research. ≥99% HPLC-verified. For research use only.
CJC-1295 Without DAC 5mg + Ipamorelin 5mg in one vial
Every lot independently verified by third-party laboratories
Full Certificate of Analysis with HPLC, mass spec, and composition data
CJC + IPA is a precision-blended combination of CJC-1295 Without DAC (Mod GRF 1-29, 5mg) and Ipamorelin (5mg) in a single lyophilized vial. This blend combines a GHRH analog with a selective growth hormone secretagogue.
CJC-1295 Without DAC is a 29-amino acid modified GHRH analog, while Ipamorelin is a pentapeptide GHS that selectively targets the ghrelin receptor. Both compounds have extensive published research examining their receptor binding profiles.
All components manufactured under cGMP-equivalent protocols and verified to ≥99% purity. Full COA included.
Supplied as a lyophilized white powder. Soluble in sterile water and bacteriostatic water. For research and laboratory use only.
A precision blend of CJC-1295 Without DAC (5mg) and Ipamorelin (5mg) combining a GHRH analog with a selective GH secretagogue. For research use only.
Both components verified at ≥99% purity via HPLC. Full COA with composition data included.
Lyophilized: -20°C long-term, stable at 2–8°C for 90 days. Reconstituted: 2–8°C, use within 28 days. Protect from light.
Yes. Every order includes a COA with HPLC chromatography and composition verification for both components.
Orders before 2PM EST ship same day. Standard delivery is 2–4 business days within the continental US. All orders include tracking.
Still have questions about CJC + IPA or any of our research compounds?
Contact Our Research Team →
